Baidu Ventures has re-upped its commitment to the DNA and RNA sequencing equipment manufacturer, joining investors including Sunshine Insurance’s Riverhead Capital vehicle.
China-based genomics technology developer QitanTech received RMB400m ($63m) in series B funding yesterday from investors including internet company Baidu and insurance provider Sunshine Insurance Group.
GL Ventures, the venture capital arm of private equity group Hillhouse Capital, co-led the round with CDH Venture and Growth Capital, a fund owned by asset manager CDH Investments.
Alwin Capital, BioTrack Capital, Gaorong Capital, Huagai Capital, Yinxinggu Capital and ZGC Co-Innovation Fund filled out the investors. Baidu was represented by its Baidu Ventures unit…
